Omni Star Financial Group, Inc. Krystal Biotech, Inc. Transaction History
Omni Star Financial Group, Inc.
- $115 Million
- Q1 2025
A detailed history of Omni Star Financial Group, Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Omni Star Financial Group, Inc. holds 2,026 shares of KRYS stock, worth $256,653. This represents 0.32% of its overall portfolio holdings.
Number of Shares
2,026Holding current value
$256,653% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$500 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$358 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$346 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$155 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$121 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.25B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...